Annie Beuve

Prof. Annie Beuve

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2017 in Antioxidants & Redox Signaling
Verified
Journal Article
Open access
ABAnnie Beuve
Annie Beuve
Significance: Soluble guanylyl cyclase (sGC), which produces the second messenger cyclic guanosine 3′, 5′-monophosphate (cGMP), is at the crossroads of nitric oxide (NO) signaling: sGC catalytic activity is both stimulated by NO binding to the heme and inhibited by NO modification of its cysteine (Cys) thiols (S-nitrosation). Modulation of sGC activity by thiol oxidation makes sGC a therapeutic target for pathologies originating from oxidative or nitrosative stress. sGC has an unusually high percentage of Cys for a cytosolic protein, the majority solvent exposed and therefore accessible modulatory targets for biological and pathophysiological signaling. Recent Advances: Thiol oxidation of sGC contributes to the development of cardiovascular diseases by decreasing NO-dependent cGMP production and thereby vascular reactivity. This thiol-based resistance to NO ( e.g ., increase in peripheral resistance) is observed in hypertension and hyperaldosteronism. Critical Issues: Some roles of specific Cys thiols have been identified in vitro . So far, it has not been possible to pinpoint the roles of specific Cys of sGC in vivo and to investigate the molecular mechanisms in an animal model. Future Directions: The role of Cys as redox sensors, intermediates of activation, and mediators of change in sGC conformation, activity, and dimerization remains largely unexplored. To understand modulation of sGC activity, it is critical to investigate the roles of specific oxidative thiol modifications that are formed during these processes. Where the redox state of sGC thiols contribute to pathologies (vascular resistance and sGC desensitization by NO donors), it becomes crucial to design therapeutic strategies to restore sGC to its normal, physiological thiol redox state. Antioxid. Redox Signal. 26, 137–149.

1 September 2017 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
CHCan Huang
Can Huang
MAMaryam Alapa
Maryam Alapa
PSPing Shu
Ping Shu
NNNarayani Nagarajan
Narayani Nagarajan
CWChanggong Wu
Changgong Wu
ABAnnie Beuve
Annie Beuve
Nitric oxide (NO) modulates many physiological events through production of cGMP from its receptor, the NO-sensitive guanylyl cyclase (GC1). NO also appears to function in a cGMP-independent manner, via S-nitrosation (SNO), a redox-based modification of cysteine thiols. Previously, we have shown that S-nitrosated GC1 (SNO-GC1) is desensitized to NO stimulation following prolonged NO exposure or under oxidative/nitrosative stress. In animal models of nitrate tolerance and angiotensin II-induced hypertension, decreased vasodilation in response to NO correlates with GC1 thiol oxidation, but the physiological mechanism that resensitizes GC1 to NO and restores basal activity is unknown. Because GC1 interacts with the oxidoreductase protein-disulfide isomerase, we hypothesized that thioredoxin-1 (Trx1), a cytosolic oxidoreductase, could be involved in restoring GC1 basal activity and NO sensitivity because the Trx/thioredoxin reductase (TrxR) system maintains thiol redox homeostasis. Here, by manipulating activity and levels of the Trx1/TrxR system and by using a Trx1-Trap assay, we demonstrate that Trx1 modulates cGMP synthesis through an association between Trx1 and GC1 via a mixed disulfide. A proximity ligation assay confirmed the endogenous Trx1–GC1 complex in cells. Mutational analysis suggested that Cys609 in GC1 is involved in the Trx1–GC1 association and modulation of GC1 activity. Functionally, we established that Trx1 protects GC1 from S-nitrosocysteine–induced desensitization. A computational model of Trx1–GC1 interaction illustrates a possible mechanism for Trx1 to maintain basal GC1 activity and prevent/rescue GC1 desensitization to NO. The etiology of some oxidative vascular diseases may very well be explained by the dysfunction of the Trx1–GC1 association.

2 August 2022 in Redox Biology
Verified
Journal Article
Open access
CCChuanlong Cui
Chuanlong Cui
CWChanggong Wu
Changgong Wu
PSPing Shu
Ping Shu
TLTong Liu
Tong Liu
HLHong Li
Hong Li
ABAnnie Beuve
Annie Beuve
Soluble guanylyl cyclase (GC1) is an α/β heterodimer producing cGMP when stimulated by nitric oxide (NO). The NO-GC1-cGMP pathway is essential for cardiovascular homeostasis but is disrupted by oxidative stress, which causes GC1 desensitization to NO by heme oxidation and S-nitrosation (SNO) of specific cysteines. We discovered that under these conditions, GC1-α subunit increases cellular S-nitrosation via transfer of nitrosothiols to other proteins (transnitrosation) in cardiac and smooth muscle cells. One of the GC1 SNO-targets was the oxidized form of Thioredoxin1 (oTrx1), which is unidirectionally transnitrosated by GC1 with αC610 as a SNO-donor. Because oTrx1 itself drives transnitrosation, we sought and identified SNO-proteins targeted by both GC1 and Trx1. We found that transnitrosation of the small GTPase RhoA by SNO-GC1 requires oTrx1 as a nitrosothiol relay, suggesting a SNO-GC1→oTrx1→RhoA cascade. The RhoA signaling pathway, which is antagonized by the canonical NO-cGMP pathway, was alternatively inhibited by GC1-α-dependent S-nitrosation under oxidative conditions. We propose that SNO-GC1, via transnitrosation, mediates adaptive responses triggered by oxidation of the canonical NO-cGMP pathway.

2 December 2017 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
PCPierre‐Antoine Crassous
Pierre‐Antoine Crassous
PSPing Shu
Ping Shu
CHCan Huang
Can Huang
RGRichard Gordan
Richard Gordan
PBPeter Brouckaert
Peter Brouckaert
ABAnnie Beuve
Annie Beuve
Background: Guanylyl cyclase, a heme‐containing α1β1 heterodimer ( GC 1), produces cGMP in response to Nitric oxide ( NO ) stimulation. The NO ‐ GC1 ‐ cGMP pathway negatively regulates cardiomyocyte contractility and protects against cardiac hypertrophy–related remodeling. We recently reported that the β1 subunit of GC 1 is detected at the intercalated disc with connexin 43 (Cx43). Cx43 forms gap junctions ( GJs ) at the intercalated disc that are responsible for electrical propagation. We sought to determine whether there is a functional association between GC 1 and Cx43 and its role in cardiac homeostasis. Methods and Results: GC 1 and Cx43 immunostaining at the intercalated disc and coimmunoprecipitation from membrane fraction indicate that GC 1 and Cx43 are associated. Mice lacking the α subunit of GC 1 ( GC α1 knockout mice) displayed a significant decrease in GJ function (dye‐spread assay) and Cx43 membrane lateralization. In a cardiac‐hypertrophic model, angiotensin II treatment disrupted the GC1‐Cx43 association and induced significant Cx43 membrane lateralization, which was exacerbated in GC α1 knockout mice. Cx43 lateralization correlated with decreased Cx43‐containing GJs at the intercalated disc, predictors of electrical dysfunction. Accordingly, an ECG revealed that angiotensin II –treated GC α1 knockout mice had impaired ventricular electrical propagation. The phosphorylation level of Cx43 at serine 365, a protein‐kinase A upregulated site involved in trafficking/assembly of GJs , was decreased in these models. Conclusions: GC 1 modulates ventricular Cx43 location, hence GJ function, and partially protects from electrical dysfunction in an angiotensin II hypertrophy model. Disruption of the NO ‐ cGMP pathway is associated with cardiac electrical disturbance and abnormal Cx43 phosphorylation. This previously unknown NO /Cx43 signaling could be a protective mechanism against stress‐induced arrhythmia.

21 February 2025 in The Journal of Physiology
Verified
Journal Article
Open access
PBPía C. Burboa
Pía C. Burboa
PGPablo S. Gaete
Pablo S. Gaete
PSPing Shu
Ping Shu
PAPriscila A. Araujo
Priscila A. Araujo
ABAnnie Beuve
Annie Beuve
MLMauricio A Lillo
Mauricio A Lillo
S‐nitrosylation of Cx43 gap junction channels critically regulates communication between smooth muscle cells and endothelial cells. This post‐translational modification also induces the opening of undocked Cx43 hemichannels. However, its specific impact on vasomotor regulation remains unclear. Considering the role of endothelial TRPV4 channel activation in promoting vasodilatation through nitric oxide (NO) production, we investigated the direct modulation of endothelial Cx43 hemichannels by TRPV4 channel activation. Using the proximity ligation assay, we identified that Cx43 and TRPV4 are found in close proximity in the endothelium of resistance arteries. In primary endothelial cell (EC) cultures from resistance arteries, GSK 1016790A‐induced TRPV4 activation enhances eNOS activity, increases NO production, and opens Cx43 hemichannels via direct S‐nitrosylation. Notably, the elevated intracellular Ca2+ levels caused by TRPV4 activation were reduced by blocking Cx43 hemichannels. In ex vivo mesenteric arteries, inhibiting Cx43 hemichannels reduced endothelial hyperpolarization without affecting NO production in ECs, underscoring a critical role of TRPV4–Cx43 signalling in endothelial electrical behaviour. We perturbed the proximity of Cx43/TRPV4 by disrupting lipid rafts in ECs using β‐cyclodextrin. Under these conditions, hemichannel activity, Ca2+ influx and endothelial hyperpolarization were blunted upon GSK stimulation. Intravital microscopy of mesenteric arterioles in vivo further demonstrated that inhibiting Cx43 hemichannel activity, NO production and disrupting endothelial integrity reduce TRPV4‐induced relaxation. These findings underscore a new pivotal role of the Cx43 hemichannel associated with the TRPV4 signalling pathway in modulating endothelial electrical behaviour and vasomotor tone regulation. image Key points: TRPV4‐Cx43 interaction in endothelial cells: the study reveals a close proximity between Cx43 proteins and TRPV4 channels in endothelial cells of resistance arteries, establishing a functional interaction that is critical for vascular regulation. S‐nitrosylation of Cx43 hemichannels: TRPV4 activation via GSK treatment induces S‐nitrosylation of Cx43, facilitating the opening of Cx43 hemichannels. TRPV4‐mediated calcium signalling: activation of TRPV4 leads to increased intracellular Ca2+ levels in endothelial cells, an effect that is mitigated by the inhibition of Cx43 hemichannels, indicating a regulatory feedback mechanism between these two channels. Endothelial hyperpolarization and vasomotor regulation: Blocking Cx43 hemichannels impairs endothelial hyperpolarization in mesenteric arteries, without affecting NO production, suggesting a role for Cx43 in modulating endothelial electrical behaviour and contributing to vasodilatation. In vivo role of Cx43 hemichannels in vasodilatation: intravital microscopy of mouse mesenteric arterioles demonstrated that inhibiting Cx43 hemichannel activity and disrupting endothelial integrity significantly impair TRPV4‐induced vasodilatation, highlighting the crucial role of Cx43 in regulating endothelial function and vascular relaxation.

1 January 2021 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
MAMaryam Alapa
Maryam Alapa
CCChuanlong Cui
Chuanlong Cui
PSPing Shu
Ping Shu
HLHong Li
Hong Li
VKVlad Kholodovych
Vlad Kholodovych
ABAnnie Beuve
Annie Beuve